MKI67 and COVID-19: We observed that MKI67-expressing TCR+ T cells within the GEX dividing T/NK cluster were increased in COVID-19 patients, which was further validated by using flow cytometry with the same samples (Fig. 6b, c) and a different cohort, specifically in CD4+ T cells from progressive patients (Supplementary Fig. 14c, d).